HolderBook

BARINTHUS BIOTHERAPEUTICS PL (BRNS)

Institutional ownership reported to the SEC as of Q2 2026, across 21 quarters.

15
Reporting holders
$7.8M
Reported value
22.5%
Of shares outstanding
0.0%
Held as options
+1
Holder change

Institutions report 9,203,348 shares against 40,848,893 outstanding. Shares only - option lines are excluded, which is why this can be compared with the company at all. The count comes from the cover page of the company's own most recent report, so it is dated when that was filed rather than at quarter end.

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
M&G PLC$5.2M5,197,3490.03%10qHELD
HSG Holding Ltd$937.5K1,420,4730.08%17qHELD
GLR Partners, LLC$820.6K1,243,3770.38%2qHELD
DC Funds, LP$423.9K642,20433.82%21qHELD
Rangeley Capital, LLC$122.2K185,1360.11%3q+16.1%+$16.9K
Johns Hopkins University$80.7K122,2370.01%19qHELD
MORGAN STANLEY$71.8K108,8430.00%21q+4825.0%+$70.4K
Baird Financial Group, Inc.$69.9K105,9610.00%15qHELD
CITADEL ADVISORS LLC$50.7K76,7540.00%3q-35.5%-$27.9K
HighTower Advisors, LLC$24.7K37,4500.00%6qHELD
RENAISSANCE TECHNOLOGIES LLC$16.5K25,0000.00%14q-83.4%-$83.2K
XTX Topco Ltd$9.8K14,8190.00%newNEW
RHUMBLINE ADVISERS$7.7K11,6850.00%3qHELD
TWO SIGMA SECURITIES, LLC$7.3K11,0520.00%newNEW
UBS Group AG$6651,0080.00%newNEW

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q2 202615$7.8M9,203,3483220.0%
Q1 202614$7.9M9,297,1851210.0%
Q4 202512$6.1M6,481,3523220.0%
Q3 202513$10.3M9,136,6493210.0%
Q2 202513$9.0M9,294,2880320.0%
Q1 202513$9.1M9,470,0292130.0%
Q4 202415$10.3M9,702,3230230.0%
Q3 202417$10.6M9,549,2881430.0%
Q2 202416$11.6M9,777,4023220.0%
Q1 202412$21.0M9,558,9880110.0%
Q4 202312$36.0M9,581,9271210.0%
Q3 202313$29.1M9,562,2822120.0%
Q2 202313$19.7M9,705,1753120.0%
Q1 202310$21.3M10,047,4630310.0%
Q4 202212$21.7M9,987,6902030.0%
Q3 202211$31.2M10,095,9630230.0%
Q2 202212$27.5M6,298,1272130.0%
Q1 202210$23.8M4,627,3710230.0%
Q4 202114$54.3M4,901,5924040.0%
Q3 202115$77.6M4,927,0491440.0%
Q2 202119$76.8M4,629,64218000.0%